JEZ-567 is under clinical development by Novartis and currently in Phase I for Refractory Acute Myeloid Leukemia. According to GlobalData, Phase I drugs for Refractory Acute Myeloid Leukemia have a 68 ...

The Jetson Orin Nano is already being used in innovative ways. Sam Altman’s startup, World, employs Jetson modules in its Orb scanning device, which uses AI to authenticate human identity via iris ...